nach oben

Erschienen in:

01.06.2010 | Leitthema

Probiotika in der Kindergastroenterologie

Prävention und Therapie gastrointestinaler Krankheiten und Funktionsstörungen

verfasst von: Prof. Dr. M. Radke

Erschienen in: Monatsschrift Kinderheilkunde | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Zusammenfassung

Probiotika werden im Kindesalter zur Prävention und Therapie unterschiedlicher Krankheiten, Ernährungs- und funktioneller Störungen eingesetzt. In zunehmendem Maß erfolgt dies auf der Basis evidenzbasierter Daten. Die Bewertung der Probiotika muss die Speziesspezifität, den Applikationszeitpunkt, die Dosis-Wirkungs-Beziehung und den Wirkungsnachweis in randomisierten kontrollierten Studien (RCT) einschließen. Zur Prävention der nekrotisierenden Enterokolitis (NEC), zur Prävention und Therapie der akuten viralen Gastroenteritis und – in begrenztem Rahmen – auch zur Remissionsinduktion und -erhaltung der Colitis ulcerosa existiert eine inzwischen gesicherte Datenlage, die den klinischen Einsatz definierter probiotischer Bakterien rechtfertigen lässt.

Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 274:4453–4460

Allen SJ, Okoko B, Martinez E et al (2004) Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2:CD003048PubMed

Barbara G, Stanghellini V, Cremon C et al (2008) Probiotics and irritable bowel syndrome. J Clin Gastroenterol 42:S214–S217CrossRefPubMed

Barrett JS, Canale KEK, Gearry RB et al (2008) Probiotic effect on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol 14:5020–5024CrossRefPubMed

Begue B, Dumant C, Bambou JC et al (2006) Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J Cell Physiol 209:241–242CrossRefPubMed

Bibiloni R, Fedorak RN, Tannock GW et al (2005) VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100:1539–1546CrossRefPubMed

Bin-Nun A, Bromiker R, Wilschanski M et al (2005) Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147:192–196CrossRefPubMed

Bousvaros A, Guandalini S, Baldassano RN et al (2005) A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm Bowel Dis 11:833–839CrossRefPubMed

Brenner DM, Moeller MJ, Chey WD et al (2009) The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 104:1033–1049CrossRefPubMed

10.

Bufford JD, Gern JE (2005) The hygiene hypothesis revisited. Immunol Allergy Clin North Am 25:247–262CrossRefPubMed

11.

Canchaya C, Claesson MJ, Fitzgerald GF et al (2005) Diversity of the genus Lactobacillus revealed by comparative genomics of five species. Microbiology 152:1385–3196

12.

Claesson MJ, Sinderen D von, O’Toole PW (2007) The genus Lactobacillus – a genomic basis for understandig its diversity. FEMS Microbiol Lett 269:22–28CrossRefPubMed

13.

Clavel T, Haller D (2007) Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 13:1153–1164CrossRefPubMed

14.

Clavel T, Haller D (2007) Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation. Curr Issues Intest Microbiol 8:25–43PubMed

15.

Dani C, Biadaioli R, Bertini G et al (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective double-blind study. Biol Neonate 82:103–108CrossRefPubMed

16.

Deshpande G, Rao S, Patole S (2007) Probiotics for prevention of necrotizing enterocolitis in preterm neonates with very low birthweight: a systemic review of randomised controlled trials. Lancet 369:1614–1620CrossRefPubMed

17.

Didierlaurent A, Sirard JC, Kraehenbuhl JP et al (2002) How the gut senses its content. Cell Microbiol 4:61–72CrossRefPubMed

18.

Embleton ND, Yates R (2008) Probiotics and other preventive strategies for necrotizing enterocolitis. Semin Fetal Neonatal Med 13:35–43CrossRefPubMed

19.

Francavilla R, Lionetti E, Castallaneta SP et al (2008) Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC55730 and effect on eradication therapy: a pilot study. Helicobacter 13:127–134CrossRefPubMed

20.

Gionchetti P, Rizzello F, Venturi A et al (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305–309CrossRefPubMed

21.

Glintborg B, Dawids S, Hasselby JP et al (2006) Long-term administration of Lactobacillus reuteri (ATCC55730) has no influence on gastric mucosal inflammation and colonization of Helicobacter pylori in humans. A pilot study. Int J Probiotics Prebiotics 1:219–224

22.

Guandalini G (2008) Probiotics for children with diarrhea. J Clin Gastroenterol 42:S53–S57CrossRefPubMed

23.

Guarner F, Bourdet-Sicard R, Brandtzaeg P et al (2006) Mechanisms of disease; the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3:275–284CrossRefPubMed

24.

Henker J, Müller S, Laass MW et al (2008) Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol 46:874–875CrossRefPubMed

25.

Hooper LV Wong MH, Thelin A et al (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881–884CrossRefPubMed

26.

Huynh HQ, Bruyn J de, Guan L et al (2009) Probiotic preparation (VSL#3) induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis 15:760–768CrossRefPubMed

27.

Indrio F, Riezzo G, Raimondi F et al (2008) The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 152:801–806CrossRefPubMed

28.

Johnson-Henry KC, Donato KA, Shen-Tu G et al (2008) Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O 157:H7-induced changes in epithelial barrier function. Infect Immun 76:1340–1348CrossRefPubMed

29.

Johnston BC, Supina AL, Ospina M et al (2007) Probiotics for the prevention of pediatric antibiotic-associated diarrhea (review). Cochrane Datebase Syst Rev 2:CD004827

30.

Kruis W, Fric P, Pokrotniceks J et al (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617–1623CrossRefPubMed

31.

Kukkonen K, Savilahti E, Haahtela T et al (2008) Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (symbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122:8–12CrossRefPubMed

32.

Li Y, Shimizu T, Hosaka A et al (2004) Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 45:509–515CrossRef

33.

Lierop PE van, Samson JN, Escher JC et al (2009) Role of innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 48:142–151CrossRefPubMed

34.

Lin HC, Su BH, Chen AC et al (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight preterm infants. Pediatrics 115:1–4CrossRefPubMed

35.

Lin HC, Hsu CH, Chen HL et al (2008) Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122:693–700CrossRefPubMed

36.

Lionetti E, Miniello VL, Castellaneta SP et al (2006) Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 24:1461–1468CrossRefPubMed

37.

Miele E, Pascarella F, Gianetti E et al (2009) Effect of a probiotic preparation (VSL≠3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 104:437–443CrossRefPubMed

38.

Mimura T, Rizzello F, Helwig U et al (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:108–114CrossRefPubMed

39.

Mohan R, Koebnick C, Schildt J et al (2008) Effects of Bificobacterium lactis Bb 12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res 64:418–422CrossRefPubMed

40.

Neu J (2007) Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 65:282–285CrossRefPubMed

41.

Neu J, Douglas-Escobar M, Lopez M (2007) Microbes and the developing gastrointestinal tract. Nutr Clin Pract 22:174–182CrossRefPubMed

42.

Newburg DS (2005) Innate immunity and human milk. J Nutr 135:1308–1312PubMed

43.

Niv E, Naftali T, Hallak R, Vaisman N (2005) The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome: a double blind, placebo-controlled, randomized study. Clin Nutr 24:925–931CrossRefPubMed

44.

Panigrahi P, Parida S, Pradhan L et al (2008) Long-term colonization of a Lactobacillus plantarum symbiotic preparation in the neonatal gut. J Pediatr Gastroenterol Nutr 47:45–53CrossRefPubMed

45.

Radke M (2006) Pro- und Präbiotika bei Nahrungsmittelallergien. Monatsschr Kinderheilkd 154:424–431CrossRef

46.

Rioux KP, Fedora RN (1006) Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 40:260–263CrossRef

47.

Rook GA, Brunet LR (2005) Microbes, immunoregulation, and the gut. Gut 54:317–320CrossRefPubMed

48.

Ruemmele FM, Bier D, Marteau P et al (2009) Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediatr Gastroenterol Nutr 48:126–141CrossRefPubMed

49.

Ruszczynski M, Radzikowski A, Szajewska H (2008) Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 28:154–161PubMedCrossRef

50.

Scarpellini E, Giorgio V, Gabrielli M et al (2009) Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr 155:416–420CrossRefPubMed

51.

Schwiertz A, Gruhl B, Löbnitz M et al (2003) Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast fed, full-term infants. Pediatr Res 54:393–399CrossRefPubMed

52.

Shornikova A, Casas I, Isolauri E et al (1997) Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 24:399–404CrossRefPubMed

53.

Szajewska H, Kotowska M, Mrukowicz JZ et al (2001) Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138:361–365CrossRefPubMed

54.

Szajewska H, Mrukowicz JZ et al (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33:S17–S25CrossRefPubMed

55.

Szymanski H, Pejcz J, Jawien M et al (2006) Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains: a randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 23:247–253CrossRefPubMed

56.

Turner JR (2006) Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 169:1901–1909CrossRefPubMed

57.

Underwood MA, Salzman NH, Bennet SH et al (2009) A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr 48:216–225CrossRefPubMed

58.

Valeur N, Engel P, Carbajal N et al (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environm Microbiol 70:1176–1181CrossRef

59.

Van Niel CW, Feudtner C, Garrison MM et al (2002) Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics 109:678–684CrossRef

60.

Weizman Z, Alsheikh A (2006) Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study. J Am Coll Nutr 25:415–419PubMed

61.

Weizman Z, Asli G, Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115:5–9PubMed

Titel: Probiotika in der Kindergastroenterologie
Prävention und Therapie gastrointestinaler Krankheiten und Funktionsstörungen
verfasst von: Prof. Dr. M. Radke
Publikationsdatum: 01.06.2010
Verlag: Springer-Verlag
Erschienen in: Monatsschrift Kinderheilkunde / Ausgabe 6/2010
Print ISSN: 0026-9298
Elektronische ISSN: 1433-0474
DOI: https://doi.org/10.1007/s00112-009-2156-x

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Probiotika in der Kindergastroenterologie

Prävention und Therapie gastrointestinaler Krankheiten und Funktionsstörungen

Zusammenfassung

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Update Pädiatrie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Prävention der kindlichen Adipositas während der Schwangerschaft

Prävention des Plötzlichen Kindstodes

Behandlung der chronischen Hepatitis C

Verabschiedung von Prof. Dr. Dr. Dietrich Reinhardt

Prävention

Neugeborenenhörscreening

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Update Pädiatrie